BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 11163822)

  • 1. Clinical outcomes and fertility after conservative treatment of ovarian borderline tumors.
    Morice P; Camatte S; El Hassan J; Pautier P; Duvillard P; Castaigne D
    Fertil Steril; 2001 Jan; 75(1):92-6. PubMed ID: 11163822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of clinicopathologic and surgical factors on relapse and pregnancy in young patients (≤40 years old) with borderline ovarian tumors.
    Fang C; Zhao L; Chen X; Yu A; Xia L; Zhang P
    BMC Cancer; 2018 Nov; 18(1):1147. PubMed ID: 30463533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical outcome of cystectomy compared with unilateral salpingo-oophorectomy as fertility-sparing treatment of borderline ovarian tumors.
    Yinon Y; Beiner ME; Gotlieb WH; Korach Y; Perri T; Ben-Baruch G
    Fertil Steril; 2007 Aug; 88(2):479-84. PubMed ID: 17408624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fertility results after conservative treatment of advanced stage serous borderline tumour of the ovary.
    Camatte S; Morice P; Pautier P; Atallah D; Duvillard P; Castaigne D
    BJOG; 2002 Apr; 109(4):376-80. PubMed ID: 12013157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A retrospective study of 27 ovarian tumors of low malignant potential.
    Demeter A; Csapó Z; Szánthó A; Bálega J; Sipos N; Papp Z
    Eur J Gynaecol Oncol; 2002; 23(5):415-8. PubMed ID: 12440814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prognosis and fertility after conservative treatment for ovarian tumors of limited malignity: review of 68 cases].
    Camatte S; Rouzier R; Boccara-Dekeyser J; Pautier P; Pomel C; Lhomme C; Duvillard P; Castaigne D; Morice P
    Gynecol Obstet Fertil; 2002; 30(7-8):583-91. PubMed ID: 12199041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fertility after conservative treatment for borderline ovarian tumors: a French multicenter study.
    Fauvet R; Poncelet C; Boccara J; Descamps P; Fondrinier E; Daraï E
    Fertil Steril; 2005 Feb; 83(2):284-90; quiz 525-6. PubMed ID: 15705364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oncologic and reproductive outcome after fertility-saving surgery in ovarian cancer.
    Ayhan A; Celik H; Taskiran C; Bozdag G; Aksu T
    Eur J Gynaecol Oncol; 2003; 24(3-4):223-32. PubMed ID: 12807228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Borderline tumors of the ovary: fertility treatment, conservative management, and pregnancy outcome.
    Gotlieb WH; Flikker S; Davidson B; Korach Y; Kopolovic J; Ben-Baruch G
    Cancer; 1998 Jan; 82(1):141-6. PubMed ID: 9428490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcome of reproductive age women with stage IA or IC invasive epithelial ovarian cancer treated with fertility-sparing therapy.
    Schilder JM; Thompson AM; DePriest PD; Ueland FR; Cibull ML; Kryscio RJ; Modesitt SC; Lu KH; Geisler JP; Higgins RV; Magtibay PM; Cohn DE; Powell MA; Chu C; Stehman FB; van Nagell J
    Gynecol Oncol; 2002 Oct; 87(1):1-7. PubMed ID: 12468335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Salpingo-oophorectomy versus cystectomy in patients with borderline ovarian tumors: a systemic review and meta-analysis on postoperative recurrence and fertility.
    Wang P; Fang L
    World J Surg Oncol; 2021 Apr; 19(1):132. PubMed ID: 33882931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fertility-sparing surgery for young patients with borderline ovarian tumors (BOTs): single institution experience.
    Chen RF; Li J; Zhu TT; Yu HL; Lu X
    J Ovarian Res; 2016 Mar; 9():16. PubMed ID: 26988551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conservative surgery in ovarian borderline tumours: a meta-analysis with emphasis on recurrence risk.
    Vasconcelos I; de Sousa Mendes M
    Eur J Cancer; 2015 Mar; 51(5):620-31. PubMed ID: 25661104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety of conservative management and fertility outcome in women with borderline tumors of the ovary.
    Donnez J; Munschke A; Berliere M; Pirard C; Jadoul P; Smets M; Squifflet J
    Fertil Steril; 2003 May; 79(5):1216-21. PubMed ID: 12738521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Ovarian low malignant potential tumor: how to preserve fertility?].
    Koskas M; Madelenat P; Yazbeck C
    Gynecol Obstet Fertil; 2009; 37(11-12):942-50. PubMed ID: 19819742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncofertility outcomes after fertility-sparing treatment of bilateral serous borderline ovarian tumors: results of a large retrospective study.
    Jia SZ; Xiang Y; Yang JJ; Shi JH; Jia CW; Leng JH
    Hum Reprod; 2020 Feb; 35(2):328-339. PubMed ID: 32048711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conservative surgery for borderline ovarian tumors: a review.
    Tinelli R; Tinelli A; Tinelli FG; Cicinelli E; Malvasi A
    Gynecol Oncol; 2006 Jan; 100(1):185-91. PubMed ID: 16216320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Feasibility, safety, and efficacy of conservative laparoscopic treatment of borderline ovarian tumors.
    Tinelli R; Malzoni M; Cosentino F; Perone C; Tinelli A; Malvasi A; Cicinelli E
    Fertil Steril; 2009 Aug; 92(2):736-41. PubMed ID: 18793773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fertility-sparing surgery for ovarian low malignant potential tumors.
    Rao GG; Skinner EN; Gehrig PA; Duska LR; Miller DS; Schorge JO
    Gynecol Oncol; 2005 Aug; 98(2):263-6. PubMed ID: 15964063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes after conservative treatment of advanced-stage serous borderline tumors of the ovary.
    Uzan C; Kane A; Rey A; Gouy S; Duvillard P; Morice P
    Ann Oncol; 2010 Jan; 21(1):55-60. PubMed ID: 19608617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.